GIFLF:OTCMKTS
Grifols SA Class A
USD 11,13
0,00%
(0,00) 1D
15 Sep., 15:11:14 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIFLF...
Mkt. cap
6,64 mjd
Avg. vol.
543,00
Volume
0,00
52-wk high
USD 12,90
52-wk low
USD 10,13
Beta
0,86
Shares outstanding
426,13 m
No. of employees
25 k
Mkt. cap
6,64 mjd
Avg. vol.
543,00
Volume
0,00
52-wk high
USD 12,90
52-wk low
USD 10,13
Beta
0,86
Shares outstanding
426,13 m
No. of employees
25 k
News stories
From web sources and news partners
AD HOC NEWS
·
15 minute gelede
Grifols stock reports 28.70 percent profit growth in H1
The New York Times
·
1 maand gelede
After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A